ATE454151T1 - Arzneimittel für nicht-cardiogene diastolische dysfunktion - Google Patents

Arzneimittel für nicht-cardiogene diastolische dysfunktion

Info

Publication number
ATE454151T1
ATE454151T1 AT99902868T AT99902868T ATE454151T1 AT E454151 T1 ATE454151 T1 AT E454151T1 AT 99902868 T AT99902868 T AT 99902868T AT 99902868 T AT99902868 T AT 99902868T AT E454151 T1 ATE454151 T1 AT E454151T1
Authority
AT
Austria
Prior art keywords
cardiogenic
diastolic dysfunction
medicinal products
dysfunction
diastolic
Prior art date
Application number
AT99902868T
Other languages
English (en)
Inventor
Hisashi Kawasumi
Yuji Abe
Naoya Satoh
Yoshimi Kitada
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE454151T1 publication Critical patent/ATE454151T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99902868T 1998-02-12 1999-02-10 Arzneimittel für nicht-cardiogene diastolische dysfunktion ATE454151T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2967898 1998-02-12
PCT/JP1999/000562 WO1999040919A1 (en) 1998-02-12 1999-02-10 Remedies for cardiac dilastolic disorders

Publications (1)

Publication Number Publication Date
ATE454151T1 true ATE454151T1 (de) 2010-01-15

Family

ID=12282784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902868T ATE454151T1 (de) 1998-02-12 1999-02-10 Arzneimittel für nicht-cardiogene diastolische dysfunktion

Country Status (8)

Country Link
EP (1) EP1062948B1 (de)
JP (1) JP4635339B2 (de)
KR (1) KR100571691B1 (de)
CN (1) CN1198617C (de)
AT (1) ATE454151T1 (de)
CA (1) CA2320627C (de)
DE (1) DE69941897D1 (de)
WO (1) WO1999040919A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124632A1 (en) * 2001-03-13 2005-06-09 Yoshimi Kitada Remedies and/or preventives for diabetic ischemic heart diseases
AR034887A1 (es) * 2001-07-25 2004-03-24 Mitsubishi Pharma Corp Medicamento inhibidor del sistema de intercambio sodio/calcio
WO2003011296A1 (fr) * 2001-07-30 2003-02-13 Mitsubishi Pharma Corporation Preparations pharmaceutiques stables contenant comme principe actif des derives de l'acide aminobenzenesulphonique
JPWO2004019946A1 (ja) * 2002-08-30 2005-12-15 三菱ウェルファーマ株式会社 細胞内ナトリウムイオン過蓄積抑制薬
JPWO2004022545A1 (ja) * 2002-09-06 2005-12-22 三菱ウェルファーマ株式会社 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
US20090318461A1 (en) * 2006-07-21 2009-12-24 Chika Ohno Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid
JPWO2008010567A1 (ja) * 2006-07-21 2009-12-17 田辺三菱製薬株式会社 ５−メチル‐２‐（ピペラジン−１−イル）ベンゼンスルホン酸の塩形態又は溶媒和物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686438B2 (ja) * 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
JP3083544B2 (ja) * 1990-09-27 2000-09-04 三菱化学株式会社 心疾患を予防または治療する薬剤
CA2192731C (en) * 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
JP3215338B2 (ja) * 1995-12-15 2001-10-02 三菱化学株式会社 アミノベンゼンスルホン酸誘導体一水和物及びその製造方法
JPH10298077A (ja) * 1997-04-24 1998-11-10 Mitsubishi Chem Corp 心筋症の治療、予防剤

Also Published As

Publication number Publication date
WO1999040919A1 (en) 1999-08-19
KR100571691B1 (ko) 2006-04-17
CN1296411A (zh) 2001-05-23
KR20010040837A (ko) 2001-05-15
DE69941897D1 (de) 2010-02-25
CA2320627A1 (en) 1999-08-19
JP4635339B2 (ja) 2011-02-23
CA2320627C (en) 2007-10-30
CN1198617C (zh) 2005-04-27
EP1062948A1 (de) 2000-12-27
EP1062948A4 (de) 2002-07-17
EP1062948B1 (de) 2010-01-06

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
IS2863B (is) Arípíprazóllausn til gjafar um munn
KR920019342A (ko) 골질환 치료제
MXPA02003933A (es) Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
DE69528005D1 (de) Prolineamid-Derivate
AR023957A1 (es) Pirazol carboxamidas utiles para el tratamiento de la obesidad y otros trastornos.
BR0109703A (pt) Derivados de piperazina
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
PT1401841E (pt) Derivados substituidos de 1-oxa-2,8-diaza-espiro[4.5]dec-2-eno como medicamentos para o tratamento da dor
SI1546127T1 (sl) Novi pirimidinamidni derivati in njihova uporaba
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
CY1109334T1 (el) Παραγωγα ν-αλκοξυαλκυλο-ν,ν-διαλκυλαμινης ή αλατα αυτης και φαρμακα δια νευρο-εκφυλιστικας νοσους περιεχοντα αυτα
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE69941897D1 (de) Arzneimittel für nicht-cardiogene diastolische dysfunktion
EP1426360A4 (de) 2-phenyl-3-heteroaryl propionsäure derivate und deren salze, und diese enthaltende arzneimittel
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE0002729D0 (sv) Novel compound form
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties